Johnson & Johnson (XSWX:JNJ) Cyclically Adjusted FCF per Share: CHF6.65 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:JNJ Johnson & Johnson XSWX:JNJ
76 GF Score
Price CHF205.10
GF Value CHF154.50
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Johnson & Johnson Cyclically Adjusted FCF per Share?

Johnson & Johnson XSWX:JNJ -1.82% 76 Cyclically Adjusted FCF per Share is CHF6.65 as of Mar. 2026. GuruFocus rates XSWX:JNJ with a GF Score™ of 76/100 and a GF Value™ of CHF154.50 (Significantly Overvalued). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Johnson & Johnson's adjusted free cash flow per share for the three months ended in Mar. 2026 was CHF0.472. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is CHF6.65 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Johnson & Johnson's average Cyclically Adjusted FCF Growth Rate was 2.90% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 3.60% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 5.60% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 5.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Johnson & Johnson was 18.20% per year. The lowest was 3.60% per year. And the median was 7.70% per year.

As of today (2026-07-15), Johnson & Johnson's current stock price is CHF205.10. Johnson & Johnson's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was CHF6.65. Johnson & Johnson's Cyclically Adjusted Price-to-FCF of today is 30.84.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Johnson & Johnson was 31.31. The lowest was 17.69. And the median was 23.69.


Johnson & Johnson  (XSWX:JNJ) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Johnson & Johnson's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=205.10/6.65
=30.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Johnson & Johnson was 31.31. The lowest was 17.69. And the median was 23.69.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Johnson & Johnson Cyclically Adjusted FCF per Share Related Terms


Johnson & Johnson Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Johnson & Johnson's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Johnson & Johnson Cyclically Adjusted FCF per Share Chart

Johnson & Johnson Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Johnson & Johnson Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 6.65 0.00

XSWX:JNJ vs ABBV, MRK, AMGN: Cyclically Adjusted FCF per Share Comparison

For the Drug Manufacturers - General subindustry, Johnson & Johnson's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Johnson & Johnson Cyclically Adjusted Price-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Johnson & Johnson's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Johnson & Johnson's Cyclically Adjusted Price-to-FCF falls into.


XSWX:JNJ
76GF Score
Johnson & Johnson XSWX:JNJ
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Johnson & Johnson Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Johnson & Johnson's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.472/330.2130*330.2130
=0.472

Current CPI (Mar. 2026) = 330.2130.

Johnson & Johnson Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 1.321 241.018 1.810
201609 1.616 241.428 2.210
201612 2.049 241.432 2.802
201703 0.856 243.801 1.159
201706 1.795 244.955 2.420
201709 1.925 246.819 2.575
201712 1.751 246.524 2.345
201803 1.023 249.554 1.354
201806 1.893 251.989 2.481
201809 1.936 252.439 2.532
201812 1.792 251.233 2.355
201903 1.070 254.202 1.390
201906 1.876 256.143 2.418
201909 2.516 256.759 3.236
201912 1.889 256.974 2.427
202003 0.982 258.115 1.256
202006 0.996 257.797 1.276
202009 2.621 260.280 3.325
202012 2.335 260.474 2.960
202103 1.182 264.877 1.474
202106 1.529 271.696 1.858
202109 2.602 274.310 3.132
202112 1.488 278.802 1.762
202203 1.175 287.504 1.350
202206 1.716 296.311 1.912
202209 1.950 296.808 2.169
202212 1.321 296.797 1.470
202303 0.850 301.836 0.930
202306 1.049 305.109 1.135
202309 2.301 307.789 2.469
202312 2.064 306.746 2.222
202403 1.042 312.332 1.102
202406 1.719 314.175 1.807
202409 1.994 315.301 2.088
202412 1.776 315.605 1.858
202503 1.227 319.799 1.267
202506 0.834 322.561 0.854
202509 2.621 324.800 2.665
202512 1.785 324.054 1.819
202603 0.472 330.213 0.472

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of CHF6.65 mean?
Johnson & Johnson (XSWX:JNJ) has a Cyclically Adjusted FCF per Share of CHF6.65 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Johnson & Johnson and its competitors.
Is Johnson & Johnson's Cyclically Adjusted FCF per Share too high?
Johnson & Johnson's current Cyclically Adjusted FCF per Share is CHF6.65. Overall, Johnson & Johnson has a GF Score™ of 76/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Johnson & Johnson's Cyclically Adjusted FCF per Share compare to ABBV and MRK?
Johnson & Johnson's Cyclically Adjusted FCF per Share of CHF6.65 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Drug Manufacturers company?
A good Cyclically Adjusted FCF per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Johnson & Johnson and its competitors. Johnson & Johnson's current Cyclically Adjusted FCF per Share is CHF6.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Johnson & Johnson stock overvalued right now?
Based on GuruFocus' analysis, Johnson & Johnson (XSWX:JNJ) is currently considered Significantly Overvalued. The stock's GF Value™ is CHF154.50, compared to a current price of CHF205.10 — trading 32.8% above its estimated fair value. The current Cyclically Adjusted FCF per Share is CHF6.65. Johnson & Johnson's overall GF Score™ is 76/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Johnson & Johnson (XSWX:JNJ), the current Cyclically Adjusted FCF per Share is CHF6.65 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Johnson & Johnson (XSWX:JNJ) Overvalued in 2026?

Based on GuruFocus' analysis, Johnson & Johnson stock appears to be overvalued. The current stock price of CHF205.10 is trading 32.8% above its estimated GF Value™ of CHF154.50. GuruFocus considers Johnson & Johnson to be Significantly Overvalued.

Key valuation signals for XSWX:JNJ:

  • Cyclically Adjusted FCF per Share: CHF6.65
  • GF Value™: CHF154.50 vs. price of CHF205.10 (32.8% above fair value)
  • GF Score™: 76/100 with 7 warning signs

No single metric tells the full story. See the XSWX:JNJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Johnson & Johnson Business Description

Address One Johnson & Johnson Plaza, New Brunswick, NJ, USA, 08933
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
76GF Score

Get the complete analysis for XSWX:JNJ

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF205.10
Price
CHF154.50
GF Value